Basics Gyre Therapeutics, Inc. IPO Date: August 21, 2015 Sector: Healthcare Industry: Biotech Market Cap: $768.74M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 3.80% Avg Daily Range (30 D): $0.16 | 2.01% Avg Daily Range (90 D): $0.20 | 2.56% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .06M Trade Size Avg Trade Size (Sh.): 241 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 61 Institutional Trades Total Inst.Trades: 121 Avg Inst. Trade: $1.59M Avg Inst. Trade (30 D): $2.54M Avg Inst. Trade (90 D): $2.54M Avg Inst. Trade Volume: .46M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.82M Avg Closing Trade (30 D): $2.54M Avg Closing Trade (90 D): $2.54M Avg Closing Volume: 577.94K     News Nov 7, 2025 @ 11:00 AM Gyre Therapeutics Reports Third Quarter 2025 and Y... Source: Gyre Therapeutics Oct 14, 2025 @ 11:00 AM Gyre Therapeutics to Present Results from Positive... Source: Prof. Lungen Lu, M.D. Aug 22, 2025 @ 11:00 AM Gyre Therapeutics Announces the Appointment of Dan... Source: Gyre Therapeutics Jun 10, 2025 @ 11:00 AM Gyre Therapeutics Announces First Dosing in Phase ... Source: N/A May 23, 2025 @ 12:57 AM Gyre Therapeutics Announces Pricing of $20.0 Milli... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $.04 $ $.03 Diluted EPS $.03 $ $ Revenue $ 30.56M $ 26.77M $ 22.06M Gross Profit $ 28.94M $ 25.62M $ 21.16M Net Income / Loss $ 8.26M $ 1.58M $ 3.73M Operating Income / Loss $ 6.93M $ 2.17M $ 2.27M Cost of Revenue $ 1.63M $ 1.15M $ .89M Net Cash Flow $ 3.79M $ 21.4M $ 3.18M PE Ratio 269.67     Splits Jan 13, 2023:   2:1 Feb 13, 2017:   1:15 Aug 21, 2015:   1:7